Biogen (BIIB) EPS (Basic) (2009 - 2026)
Biogen (BIIB) posted quarterly EPS (Basic) of $0.66 for Q2 2026, down 84.77% year-over-year from $4.33 in Q2 2025, and down 69.59% quarter-over-quarter from $2.17 in Q1 2026.
Biogen (BIIB) EPS (Basic) (2009 - 2026) Analysis & Trends
Biogen's EPS (Basic) history runs 18 years deep, the most recent figure standing at $0.66 for Q2 2026.
- In Q2 2026, EPS (Basic) fell 84.77% year-over-year to $0.66; the TTM figure through Jun 2026 stood at $5.65 (down 45.91% YoY), while the FY2025 annual figure was $8.83, down 21.27% from the prior year.
- EPS (Basic) for Q2 2026 stood at $0.66, down from $2.17 in the prior quarter.
- The five-year high for EPS (Basic) was $7.86 in Q3 2022, with the low at -$0.47 in Q3 2023.
- The 5-year median for EPS (Basic) is $2.68 (2023), against an average of $2.85.
- The sharpest annual moves came in 2022 and 2025: EPS (Basic) surged 1576.1% in 2022, then tumbled 118.22% in 2025.
- Biogen's EPS (Basic) stood at $3.78 in 2022, then tumbled by 54.52% to $1.72 in 2023, then grew by 6.49% to $1.83 in 2024, then sank by 118.22% to -$0.33 in 2025, then jumped by 297.77% to $0.66 in 2026.
- Business Quant data shows BIIB's EPS (Basic) at $0.66 in Q2 2026, $2.17 in Q1 2026, and -$0.33 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.66 Bn | 632.90 Bn | 17.26 Bn | 2.30 |
| 2 | AbbVie | 470.02 Bn | 463.46 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 379.06 Bn | 371.92 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 302.95 Bn | 295.26 Bn | 11.24 Bn | 1.71 |
| 5 | Astrazeneca | 257.68 Bn | 252.78 Bn | 12.86 Bn | 1.62 |
| 6 | Amgen | 236.97 Bn | 222.98 Bn | 7.24 Bn | 4.40 |
| 7 | Gilead Sciences | 182.78 Bn | 179.60 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 161.51 Bn | 149.81 Bn | 10.94 Bn | -0.04 |
| 9 | Gsk | 105.54 Bn | 101.37 Bn | 8.24 Bn | 0.29 |
| 10 | Biogen | 32.29 Bn | 31.00 Bn | 1.96 Bn | 0.66 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 0.66 |
| Mar 31, 2026 | 2.17 |
| Dec 31, 2025 | -0.33 |
| Sep 30, 2025 | 3.18 |
| Jun 30, 2025 | 4.33 |
| Mar 31, 2025 | 1.65 |
| Dec 31, 2024 | 1.83 |
| Sep 30, 2024 | 2.67 |
| Jun 30, 2024 | 4.01 |
| Mar 31, 2024 | 2.71 |
| Dec 31, 2023 | 1.72 |
| Sep 30, 2023 | -0.47 |
| Jun 30, 2023 | 4.10 |
| Mar 31, 2023 | 2.68 |
| Dec 31, 2022 | 3.78 |
| Sep 30, 2022 | 7.86 |
| Jun 30, 2022 | 7.22 |
| Mar 31, 2022 | 1.51 |
| Dec 31, 2021 | -0.26 |
| Sep 30, 2021 | 2.14 |